Hepatitis B Cirrhosis, mesenchymal stem cell
Showing 1 - 25 of >10,000
Liver Cirrhoses Trial in Jakarta (Allogeneic Umbilical Cord Mesenchymal Stem Cell)
Recruiting
- Liver Cirrhoses
- Allogeneic Umbilical Cord Mesenchymal Stem Cell
-
Jakarta, DKI Jakarta, IndonesiaCipto Mangunkusumo hospital
Jun 12, 2022
Cirrhosis Due to Hepatitis B Trial in Wuhan (UC-MSCs, Saline solution)
Recruiting
- Cirrhosis Due to Hepatitis B
- UC-MSCs
- Saline solution
-
Wuhan, Hubei, ChinaRenmin Hospital of Wuhan University
Aug 18, 2022
Liver Cirrhosis Trial in Haikou (UC-MSC infusion)
Recruiting
- Liver Cirrhosis
- UC-MSC infusion
-
Haikou, ChinaHaikou People's Hospital
Oct 31, 2021
Decompensated Liver Cirrhosis Trial (Human Umbilical Cord Mesenchymal Stem Cells)
Not yet recruiting
- Decompensated Liver Cirrhosis
- Human Umbilical Cord Mesenchymal Stem Cells
- (no location specified)
Jul 13, 2023
Hepatitis B Trial in Changsha (Peripheral iv)
Recruiting
- Hepatitis B
- Peripheral iv
-
Changsha, Hunan, ChinaXiangya Hospital Central South University
Jul 20, 2022
Liver Cirrhosis Trial in Kharkov (Autologous BM MSC)
Active, not recruiting
- Liver Cirrhosis
- Autologous BM MSC
-
Kharkov, UkraineInstitute of Bio-Stem Cell Rehabilitation
May 16, 2022
Decompensated Cirrhosis Trial in Beijing (Human Umbilical Cord-derived Mesenchymal Stem Cells)
Not yet recruiting
- Decompensated Cirrhosis
- Human Umbilical Cord-derived Mesenchymal Stem Cells
-
Beijing, ChinaBeijing 302 Hospital
Aug 2, 2023
Decompensated Cirrhosis Trial in Beijing (Human Umbilical Cord-derived Mesenchymal Stem Cells)
Recruiting
- Decompensated Cirrhosis
- Human Umbilical Cord-derived Mesenchymal Stem Cells
-
Beijing, ChinaBeijing 302 Hospital
Jul 28, 2022
Liver Cirrhosis Trial in Hanoi (Human umbilical cord-derived mesenchymal stem cell infusion)
Recruiting
- Liver Cirrhosis
- Human umbilical cord-derived mesenchymal stem cell infusion
-
Hanoi, VietnamVinmec Research Institute of Stem Cell and Gene Technology
Apr 14, 2022
Hepatitis B Reactivation, Hematopoietic Stem Cell Transplantation, Antiviral Drug Trial in Seoul (Entecavir)
Enrolling by invitation
- Hepatitis B Reactivation
- +3 more
-
Seoul, Korea, Republic ofJeong Won Jang
Dec 16, 2022
Hepatitis B Vaccine Post-Hematopoietic Stem Cell Transplant
Completed
- Hepatitis B
-
Bethesda, MarylandNational Heart, Lung and Blood Institute (NHLBI)
Feb 3, 2022
Decompensated Cirrhosis Trial in China (UC-MSCs, Placebo(solution without UC-MSCs))
Not yet recruiting
- Decompensated Cirrhosis
- UC-MSCs
- Placebo(solution without UC-MSCs)
-
Lanzhou, Gansu, China
- +5 more
Jan 26, 2022
Mesenchymal Stem Cell Therapy in Hemophilic Arthropathy
Recruiting
- Hemophilia A
- +2 more
-
Montpellier, FranceUhmontpellier
Dec 24, 2021
Decompensated Cirrhosis Trial in China (UC-MSCs, Saline containing 1% Human serum albumin(solution without UC-MSCs))
Recruiting
- Decompensated Cirrhosis
- UC-MSCs
- Saline containing 1% Human serum albumin(solution without UC-MSCs)
-
Lanzhou, Gansu, China
- +4 more
Nov 3, 2021
Liver Cirrhosis Trial in Singapore (Autologous BM MSC)
Recruiting
- Liver Cirrhosis
- Autologous BM MSC
-
Singapore, Singapore
- +2 more
Mar 15, 2021
Chronic Kidney Disease Stage 3B, Chronic Kidney Disease stage4 Trial in Seoul (Cellgram-CKD)
Recruiting
- Chronic Kidney Disease Stage 3B
- Chronic Kidney Disease stage4
- Cellgram-CKD
-
Seoul, Korea, Republic ofAsan Medical Center
Oct 13, 2021
Sickle Cell Disease Trial in Amsterdam (Engerix-B)
Recruiting
- Sickle Cell Disease
-
Amsterdam, NetherlandsAmsterdam Medical Centre
Jan 6, 2022
Acute-On-Chronic Liver Failure Trial in Beijing (standard medical treatment, hUC-MSC at week0, Placebo at week0)
Not yet recruiting
- Acute-On-Chronic Liver Failure
- standard medical treatment
- +10 more
-
Beijing, Beijing, Chinathe Fifth Medical Center, Chinese PLA General Hospital
Aug 15, 2023
Liver Cirrhosis, Chronic Hepatitis C Trial in Philadelphia (Rifaximin, Placebo)
Terminated
- Liver Cirrhosis
- Chronic Hepatitis C
- Rifaximin
- Placebo
-
Philadelphia, PennsylvaniaPhiladelphia VA Medical Center
Mar 8, 2021
Alcoholic Cirrhosis Trial in Korea, Republic of (Cellgram-LC)
Recruiting
- Alcoholic Cirrhosis
- Cellgram-LC
-
Bucheon, Korea, Republic of
- +10 more
Aug 17, 2021
Decompensated Liver Cirrhosis Trial in Tehran (MSC-derived exosomes)
Recruiting
- Decompensated Liver Cirrhosis
- MSC-derived exosomes
-
Tehran, Iran, Islamic Republic ofResearch Institute of Gastroenterology & Liver Diseases
May 12, 2023
Cirrhosis, Liver Trial in Hyderabad (CD 34 and MSC infusion, Standard of care for Cirrhosis management)
Completed
- Cirrhosis, Liver
- CD 34 and MSC infusion
- Standard of care for Cirrhosis management
-
Hyderabad, Telangana, IndiaAsian Institute Of Gastroenterology
Oct 20, 2020
Leukemia, Myeloid, Acute, Leukemia, Lymphoblastic, Acute, Leukemia, Myelocytic, Chronic Trial in Belgium (Mesenchymal stem
Terminated
- Leukemia, Myeloid, Acute
- +8 more
- Mesenchymal stem cells
- Isotonic solution
-
Edeghem, Antwerpen, Belgium
- +9 more
Aug 31, 2021
Acute-On-Chronic Liver Failure Trial in Shanghai (Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs))
Not yet recruiting
- Acute-On-Chronic Liver Failure
- Human umbilical cord-derived mesenchymal stem cells (hUC-MSCs)
-
Shanghai, Shanghai, ChinaRen Ji Hospital, School of Medicine, Shanghai Jiao TongUniversit
Jul 20, 2021
HBV Trial in Wuhan (hUCMSCs)
Recruiting
- HBV
- hUCMSCs
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Jun 27, 2022